Pharma Foods FY26 profit attributable to owners of parent climbs to ¥1.99 billion; net sales fall 3.1% to ¥63.22 billion

• Pharma Foods posted net sales of JPY 63.22 billion, down 3.1% year on year.
• Operating profit rose 11.2% to JPY 2.63 billion, lifting operating margin to 4.2% from 3.6%.
• Profit attributable to owners of parent returned to profit at JPY 1.99 billion; basic EPS was JPY 68.61.
• Cash flows from operating activities were negative at JPY 1.18 billion; cash and cash equivalents ended at JPY 7.69 billion.
• Forecast net sales of JPY 64 billion for FY2027; operating profit seen at JPY 3 billion, up 14%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Foods International Co. Ltd. published the original content used to generate this news brief on September 11, 2026, and is solely responsible for the information contained therein.